Gilead Sciences To Rally Around 28%? Here Are 10 Other Analyst Forecasts For Tuesday

• Morgan Stanley raised the price target for DraftKings Inc. DKNG from $23 to $25. Morgan Stanley analyst Stephen Grambling maintained an Overweight rating. DraftKings shares fell 0.2% to close at $23.49 on Monday.
• Keefe, Bruyette & Woods boosted the price target for Selective Insurance Group, Inc. SIGI from $104 to $106. Keefe, Bruyette & Woods analyst Meyer Shields maintained a Market Perform rating. Selective Insurance shares gained 0.3% to close at $103.02 on Monday.
• TD Securities cut the price target for Absolute Software Corporation ABST from $16 to $11.5. TD Securities analyst David Kwan downgraded the stock from Buy to Tender. Absolute Software shares fell 0.3% to $11.30 in pre-market trading.
• Goldman Sachs raised XP Inc. XP price target from $20 to $22. Goldman Sachs analyst Tito Labarta maintained a Buy rating. XP shares fell 0.3% to $15.71 in pre-market trading.
• UBS cut Lincoln National Corporation LNC price target from $37 to $21. UBS analyst Brian Meredith maintained a Neutral rating. Lincoln National shares rose 2.1% to $19.99 in pre-market trading.
• Mizuho raised the price target for Toast, Inc. TOST from $23 to $25. Mizuho analyst Dan Dolev maintained a Buy rating. Toast shares rose 0.8% to $19.59 in pre-market trading.
• Truist Securities cut Warner Music Group Corp. WMG price target from $37 to $32. Truist Securities analyst Matthew Thornton maintained a Buy rating. Warner Music shares rose 4.2% to close at $26.34 on Monday.
• Cantor Fitzgerald slashed Clene Inc. CLNN price target from $5 to $4. Cantor Fitzgerald analyst Charles Duncan maintained a Buy rating. Clene shares rose 3.8% to $0.9150 in pre-market trading.
• Stifel cut The Mosaic Company MOS price target from $46 to $42.. Stifel analyst Vincent Anderson maintained a Hold rating. Mosaic shares fell 0.1% to $36.58 in pre-market trading.
• Mizuho boosted HCA Healthcare, Inc HCA price target from $298 to $305. Mizuho analyst Ann Hynes maintained a Buy rating. HCA Healthcare shares fell 0.6% to $276.00 in pre-market trading.
• BMO Capital increased Gilead Sciences, Inc. GILD price target from $90 to $100. BMO Capital analyst Evan Seigerman upgraded the stock from Market Perform to Outperform. Gilead Sciences shares rose 0.3% to close at $78.38 on Monday.

Check This Out: $1.5M Bet On This Healthcare Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying